Ardelyx, Inc. (ARDX) analyst actions
Rating and price-target actions on ARDX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ARDX overview →
1 measured ARDX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C | Press release | -1.22% | -1.52% |
Keep exploring
More ARDX: earnings → · SEC filings → · ARDX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Savara, Inc. (SVRA) | 1,030 | 0.00% | 46% |
| INTREXON CORP (XON) | 1,025 | +0.05% | 52% |
| Baxter International Inc. (BAX) | 1,022 | -0.15% | 42% |
| ENDOLOGIX (ELGX) | 1,019 | -0.07% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.